Metraipolis › archive › dc_252dc6458d41
Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutations — Europe PMC PMID:41138165
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41138165
- DOI
- 10.1093/oncolo/oyaf362
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T21:18:59.773Z
- SHA-256 of the archived text
6b3395c081bb1bf0fd94c6c7d8137217f5c01ab8923dd1d24ec12f1646adc920- Stable URL of this page
https://metraipolis.com/documento/dc_252dc6458d41
How to cite
Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutations — Europe PMC PMID:41138165 — Europe PMC (en), https://europepmc.org/article/MED/41138165 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_252dc6458d41 (Metraipolis archive dc_252dc6458d41, sha256 6b3395c081bb1bf0fd94c6c7d8137217f5c01ab8923dd1d24ec12f1646adc920)
BibTeX
@misc{dc252dc6458d41,
title = {Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutations — Europe PMC PMID:41138165},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41138165},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_252dc6458d41; sha256 6b3395c081bb1bf0fd94c6c7d8137217f5c01ab8923dd1d24ec12f1646adc920},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41138165. Agents can read the archived copy with the MCP tool read_document.